Impact of Modifying Abicipar Manufacturing Process in Patients with Neovascular Age-Related Macular Degeneration: MAPLE Study Results

PURPOSE: To evaluate the impact of modifying the abicipar pegol (abicipar) manufacturing process on the safety and treatment effect of abicipar in patients with neovascular age-related macular degeneration (nAMD). METHODS: A new process for manufacturing abicipar was developed to reduce host cell im...

Descripción completa

Detalles Bibliográficos
Autores principales: Callanan, David, Khurana, Rahul N, Maturi, Raj K, Patel, Sunil, Wykoff, Charles C, Eichenbaum, David, Khanani, Arshad M, Hassan, Tarek, Badger, Hanh, Mehta, Shraddha, Le, Grace, Attar, Mayssa, Seal, Jennifer, Li, Xiao-Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Clinical Trial Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10184835/
https://www.ncbi.nlm.nih.gov/pubmed/37197577
http://dx.doi.org/10.2147/OPTH.S405994

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10184835/
https://www.ncbi.nlm.nih.gov/pubmed/37197577
http://dx.doi.org/10.2147/OPTH.S405994

Ejemplares similares